Nationwide Fund Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,450	Closed	-$320K	–	408
2017 Q3	$320K	Hold	7,450	–	–	﹤0.01%	2408
2017 Q2	$276K	Buy	7,450 +249	+3%	+$11K	﹤0.01%	2484
2017 Q1	$390K	Sell	7,201 -1,003	-12%	-$52.2K	﹤0.01%	2280
2016 Q4	$436K	Sell	8,204 -434	-5%	-$24.7K	﹤0.01%	2242
2016 Q3	$523K	Sell	8,638 -947	-10%	-$59K	﹤0.01%	2160
2016 Q2	$631K	Sell	9,585 -3,253	-25%	-$207K	﹤0.01%	2023
2016 Q1	$728K	Buy	12,838 +5,168	+67%	+$581K	﹤0.01%	1882
2015 Q4	$1.8M	Buy	7,670 +1,400	+22%	+$305K	0.01%	1413
2015 Q3	$991K	Sell	6,270 -1,755	-22%	-$497K	﹤0.01%	1726
2015 Q2	$3.04M	Sell	8,025 -1,303	-14%	-$517K	0.01%	1205
2015 Q1	$3.9M	Buy	9,328 +2,193	+31%	+$785K	0.02%	1104
2014 Q4	$1.95M	Buy	7,135 +358	+5%	+$89K	0.01%	1425
2014 Q3	$1.32M	Buy	6,777 +7	+0.1%	+$1.52K	0.01%	1684
2014 Q2	$1.66M	Buy	6,770 +854	+14%	+$193K	0.01%	1579
2014 Q1	$1.57M	Sell	5,916 -180	-3%	-$68.9K	0.01%	1508
2013 Q4	$2.21M	Sell	6,096 -1,226	-17%	-$472K	0.01%	1399
2013 Q3	$3.89M	Buy	7,322 +85	+1%	+$29.1K	0.02%	1048
2013 Q2	$1.7M	Buy	+7,237	New	+$1.42M	0.01%	1391